Cyclophosphamide as a first-line therapy in LGL leukemia

Leukemia. 2014 May;28(5):1134-6. doi: 10.1038/leu.2013.359. Epub 2013 Nov 27.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Cyclophosphamide / therapeutic use*
  • Female
  • Humans
  • Leukemia, Large Granular Lymphocytic / drug therapy*
  • Male
  • Middle Aged

Substances

  • Antineoplastic Agents, Alkylating
  • Cyclophosphamide